
David Evan Leaf MD MMSc, FASN
Acute Renal Failure, Critical Care, Renal Metabolism
Associate Professor of Medicine, Harvard Medical School; Director of Clinical and Translational Research in Acute Kidney Injury, Division of Renal Medicine, Brigham and Women's Hospital; Associate Editor, Journal of the American Society of Nephrology
Join to View Full Profile
75 Francis StBoston, MA 02115
Dr. Leaf is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am an academic physician-scientist, clinical nephrologist, full-time faculty member in the Division of Renal Medicine at Brigham and Women’s Hospital, Associate Professor of Medicine at Harvard Medical School, and an Associate Editor of Journal of the American Society of Nephrology. My lab (www.leaflab.org) conducts patient-oriented and translational research in acute kidney injury (AKI), investigating novel risk factors for its development and therapies for its prevention.
Clinical Expertise
- Acute renal failure, Sepsis, Calcium, Dysregulated Mineral Metabolism, Phosphates, acute kidney injury
Education & Training
- Mass General Brigham/Brigham and Women's Hospital/Massachusetts General HospitalFellowship, Nephrology, 2011 - 2015
- Harvard Medical SchoolMMSc, Clinical Research, 2012 - 2014
- New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 2008 - 2011
- New York University School of MedicineClass of 2008
- University of PennsylvaniaBA, Psychology, 2000 - 2004
Certifications & Licensure
- MA State Medical License 2013 - 2025
- NY State Medical License 2009 - 2012
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- Best Clinical/Translational Cancer Immunotherapy Paper Award Society for Immunotherapy of Cancer, 2022
- Editors' Choice Article (one of the top five original publications in 2020) Journal of the American Society of Nephrology, 2021
- Chair's Research Award Brigham and Women's Hospital, Department of Medicine, 2019
- Join now to see all
Clinical Trials
- Vitamin D Repletion in Stone Formers With Hypercalciuria Start of enrollment: 2010 Sep 01
- Randomized Controlled Trial of Calcitriol vs. Placebo Among Critically-ill Patients With Sepsis Start of enrollment: 2013 Feb 01
- Activated Vitamin D for the Prevention and Treatment of Acute Kidney Injury Start of enrollment: 2017 Apr 03
- Join now to see all
Publications & Presentations
PubMed
- Improving Processes of Care after Acute Kidney Injury.L Parker Gregg, David E Leaf
Journal of the American Society of Nephrology. 2025-03-01 - Another Win for SGLT2 Inhibitors in Chronic Kidney Disease.David E Leaf, Nisha Bansal
The New England Journal of Medicine. 2025-02-20 - Effect of mannitol on cisplatin-associated acute kidney injury: a target trial emulation.Shruti Gupta, Ilya G Glezerman, Jamie S Hirsch, Sophia L Wells, Kevin L Chen
Nephrology, Dialysis, Transplantation. 2025-02-04
Lectures
- To Treat or Not to Treat: Medication Toxicity and Clinical ConundrumsAmerican Society of Nephrology Kidney Week 2019 - Washington, D.C. - 11/7/2019
- Intradialytic HypertensionGrand Rounds, Division of Nephrology, Brigham & Women's Hospital and Massachusetts General Hospital
- Left ventricular assist devices and renal functionGrand Rounds, Division of Nephrology, Brigham & Women's Hospital and Massachusetts General Hospital
- Join now to see all
Press Mentions
- Glucarpidase improves recovery after chemotherapy-induced kidney toxicityJanuary 23rd, 2025
- Can Glucarpidase Help Reverse Methotrexate Kidney Damage?January 9th, 2025
- Glucarpidase Improves Outcomes in Methotrexate-Associated AKIJanuary 6th, 2025
- Join now to see all
Grant Support
- Development, Validation, and Harmonization of Methods for Collection and Measurement of NAD+ and Related Metabolites: Application to a Randomized Trial of Patients Undergoing Coronary Artery BypassBRIGHAM AND WOMEN'S HOSPITAL2024–2029
- Development, Validation, and Harmonization of Methods for Collection and Measurement of NAD+ and Related Metabolites: Application to a Randomized Trial of Patients Undergoing Coronary Artery BypassNIH/NIA2024–2029
- Hepcidin-Ferroportin-Iron Axis in Cardiac Surgery-associated Acute Kidney InjuryBRIGHAM AND WOMEN'S HOSPITAL2022–2026
- Deferoxamine for the Prevention of Acute Kidney InjuryBRIGHAM AND WOMEN'S HOSPITAL2020–2025
- Precision Medicine Approach to Vitamin D3 Administration in Critical IllnessNIH/NHLBI2019–2023
- Dysregulated Mineral Metabolism and Acute Kidney InjuryNIH/NIDDK2015–2020
- Hepcidin, Dysregulated Iron Homeostasis, and Anemia in Human Acute Kidney InjuryASN Foundation for Kidney Research Carl W. Gottschalk Research Scholar Grant2018–2019
- Dysregulated Mineral Metabolism in Critically Ill Patients with Severe AKINIH/NIDDK2015–2017
- Dysregulated Mineral Metabolism in Acute Kidney InjuryNIH/NIDDK2013–2015
Committees
- Member, Mass General Brigham Institutional Review Board 2018 - 2022
Professional Memberships
- Fellow
- American Society of OnconephrologyFounding Member
External Links
- Leaf Labhttp://www.leaflab.org
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: